Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial
| Autor: | Heerspink, Hiddo J L *, Sattar, Naveed, Pavo, Imre, Haupt, Axel, Duffin, Kevin L, Yang, Zhengyu, Wiese, Russell J, Tuttle, Katherine R, Cherney, David Z I |
|---|---|
| Zdroj: | In The Lancet Diabetes & Endocrinology November 2022 10(11):774-785 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|